Navigation Links
Researchers unlock how progesterone increases breast cancer risk
Date:1/18/2011

EAST LANSING, Mich. Researchers have identified how the hormones progesterone and estrogen interact to increase cell growth in normal mammary cells and mammary cancers, a novel finding that may explain why postmenopausal women receiving hormone replacement therapy with estrogen plus progestin are at increased risk of breast cancer.

The discovery that both estrogen and progesterone must be present for the increased production of the protein amphiregulin, which binds to mammary cells and promotes cell growth, could lead to new treatment methods for the disease, said Sandra Haslam, director of Michigan State University's Breast Cancer and the Environment Research Center and lead researcher on the project.

The study, funded by the Department of Defense's Breast Cancer Research Program and published in Hormones and Cancer, looked at why progesterone combined with estrogen may contribute to increased breast cancer risk. In the study, researchers used both the native hormone, progesterone, and a synthetic compound, progestin obtaining the same results.

The finding might help explain earlier results from the groundbreaking Women's Health Initiative showing the risk of breast cancer is significantly greater for postmenopausal women who received hormone replacement therapy with combined estrogen plus progestin compared to women receiving estrogen alone.

"Also, breast cancers that develop in women receiving estrogen plus progestin are more invasive and deadlier," Haslam said. "What is the progestin doing to increase the risk of tumor growth?"

Along with co-investigator Anastasia Kariagina, a colleague in the College of Human Medicine and Department of Physiology, Haslam identified the protein amphiregulin and its receptor as one potential culprit.

"Amphiregulin acting through its receptor, epidermal growth factor receptor along with progesterone leads to the activation of intracellular pathways that regulate cell growth," Haslam said. "When activated, this promotes normal cell growth and the growth of tumors."

The study was performed in rats because breast cancers in rats contain receptors for estrogen and progesterone similar to the human breast and tumor growth is hormone-dependent, as are the majority of human breast cancers. The research team also confirmed the same phenomenon in human breast cancer cell cultures.

In addition, the research team found that Iressa, a cancer drug that blocks the epidermal growth factor receptor, effectively stopped the proliferation caused by amphiregulin. While those studies were done only in cell cultures and not on tumors growing in animals, the results are promising, Haslam said.

"The results indicate that the interactions between estrogen, progesterone and epidermal growth factor receptor pathways may be considered relevant targets for the treatment of hormone-dependent breast cancers," she said. "This may be especially important in premenopausal breast cancer because women produce their own estrogen and progesterone.

"A combined approach of inhibiting both the hormones and the epidermal growth factor receptor may be beneficial for some women in treating hormone-dependent breast cancer."


'/>"/>

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University
Source:Eurekalert  

Related biology news :

1. In scientific first, researchers visualize naturally occurring mRNA
2. Researchers report on the early development of anti-HIV neutralizing antibodies
3. Researchers learn why PSA levels reflect prostate cancer progression
4. Adrenaline receptor frozen in action by VIB researchers
5. Researchers show how 1 gene becomes 2 (with different functions)
6. Technique allows researchers to identify key maize genes for increased yield
7. University of Houston researchers helping Pentagon build mind-controlled prosthetics
8. Researchers show environmental changes may affect vital cooperate bird behaviors
9. Washington State University researchers honored by top science society
10. 10 UC Riverside researchers recognized by the American Association for the Advancement of Science
11. AAAS honors Iowa State, Ames Lab researchers for distinguished science
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers unlock how progesterone increases breast cancer risk
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016 /PRNewswire/ ... que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que ... de tumor en 2017, con múltiples sitios previstos a lo largo ... ... en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
(Date:12/15/2016)... DUBLIN , Dec 15, 2016 ... Research and Markets has announced ... to their offering. The report forecasts the global military ... 2016-2020. The report has been prepared based on an ... market landscape and its growth prospects over the coming years. The report ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global ... ... CAGR of 16.83% during the period 2017-2021. The report ... market for 2017-2021. To calculate the market size, the report considers the ... also includes a a discussion of the key vendors operating in this ...
(Date:1/13/2017)... NY (PRWEB) , ... January 13, 2017 , ... ... meet every cuvette-related demand that it has found among its diverse customer base. ... for use in most brands electroporators including BTX and Bio-Rad. FireflySci is ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... A SUCCESS , VTI, Vertebral Technologies, Inc., announces the successful outcome of ... device. Since September 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... with short response times capable of performing routine electrochemical biosensing has increased ... electrodes provide fast, sensitive detection and quantification of various analytes in complex ...
Breaking Biology Technology: